Prognostic significance of the expression of SR-A1, encoding a novel SR-related CTD-associated factor, in breast cancer

Biological Chemistry

Volumn 387, Issue 12, 2006, Pages 1613-1618

  Leoutsakou, Theoni ^a,b   Talieri, Maroulio ^c   Scorilas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Biomarkers; Breast cancer; Gene expression; Prognosis; SCAFs; Splicing factors; SR proteins

Indexed keywords

CELL PROTEIN; MESSENGER RNA; RNA POLYMERASE II; SR A1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; FOLLOW UP; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE; MAJOR CLINICAL STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SR A1 GENE; TRANSCRIPTION REGULATION; TUMOR VOLUME;

BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; HUMANS; PROGNOSIS; RNA SPLICING; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 33751507150     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.201     Document Type: Article

References (28)

1. Bauren, G. and Wieslander, L. (1994). Splicing of Balbiani ring 1 gene pre-mRNA occurs simultaneously with transcription. Cell 76, 183-192.
2. Brodsky, A.S., Meyer, C.A., Swinburne, I.A., Hall, G., Keenan, B.J., Liu, X.S., Fox, E.A., and Silver, P.A. (2005). Genomic mapping of RNA polymerase II reveals sites of co-transcriptional regulation in human cells. Genome Biol. 6, R64.
3. Caceres, J.F. and Krainer, A.R. (1997). Mammalian pre-mRNA splicing factors. In: Frontiers in Molecular Biology: Eukaryotic mRNA Processing, A.R. Krainer, ed. (New York, USA: Oxford University Press), pp. 174-212.
4. Caceres, J.F., Screaton, G.R., and Krainer, A.R. (1998). A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 12, 55-66.
5. Cazalla, D., Newton, K., and Caceres, J.F. (2005). A novel SR-related protein is required for the second step of pre-mRNA splicing. Mol. Cell. Biol. 25, 2969-2980.
6. Faustino, N.A. and Cooper, T.A. (2003). Pre-mRNA splicing and human disease. Genes Dev. 17, 419-437.
7. Ghigna, C., Moroni, M., Porta, C., Riva, S., and Biamonti, G. (1998). Altered expression of heterogeneous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res. 58, 5818-5824.
8. Goldstrohm, A.C., Greenleaf, A.L., and Garcia-Blanco, M.A. (2001). Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. Gene 277, 31-47.
9. Graveley, B.R. (2000). Sorting out the complexity of SR protein functions. RNA 6, 1197-1211.
10. Greenleaf, A.L. (1993). Positive patches and negative noodles: linking RNA processing to transcription? Trends Biochem. Sci. 18, 117-119.
11. Hanamura, A., Caceres, J.F., Mayeda, A., Franza, B.R. Jr., and Krainer, A.R. (1998). Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4, 430-444.
12. Hirose, Y., Tacke, R., and Manley, J.L. (1999). Phosphorylated RNA polymerase II stimulates pre-mRNA splicing. Genes Dev. 13, 1234-1239.
13. Huang, Y. and Steitz, J.A. (2005). SRprises along a messenger's journey. Mol. Cell 17, 613-615.
14. Katsarou, M.E., Papakyriakou, A., Katsaros, N., and Scorilas, A. (2005). Expression of the C-terminal domain of novel human SR-A1 protein: interaction with the CTD domain of RNA polymerase II. Biochem. Biophys. Res. Commun. 334, 61-68.
15. Kim, E., Du, L., Bregman, D.B., and Warren, S.L. (1997). Splicing factors associate with hyperphosphorylated RNA polymerase II in the absence of pre-mRNA. J. Cell Biol. 136, 19-28.
16. Longman, D., McGarvey, T., McCracken, S., Johnstone, I.L., Blencowe, B.J., and Caceres, J.F. (2001). Multiple interactions between SRm160 and SR family proteins in enhancer-dependent splicing and development of C. elegans. Curr. Biol. 11, 1923-1933.
17. Mathioudaki, K., Leotsakou, T., Papadokostopoulou, A., Paraskevas, E., Ardavanis, A., Talieri, M., and Scorilas, A. (2004). SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression. Biol. Chem. 385, 785-790.
18. McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S.D., Wickens, M., and Bentley, D.L. (1997). The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 385, 357-361.
19. Mintz, P.J. and Spector, D.L. (2000). Compartmentalization of RNA processing factors within nuclear speckles. J. Struct. Biol. 129, 241-251.
20. Rosonina, E. and Blencowe, B.J. (2004). Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3′-end cleavage. RNA 10, 581-589.
21. Scorilas, A., Kyriakopoulou, L., Katsaros, D., and Diamandis, E.P. (2001). Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer. Br. J. Cancer 85, 190-198.
22. Shen, H. and Green, M.R. (2004). A pathway of sequential arginine-serine-rich domain-splicing signal interactions during mammalian spliceosome assembly. Mol. Cell 16, 363-373.
23. Shen, H., Kan, J.L., and Green, M.R. (2004). Arginine-serine-rich domains bound at splicing enhancers contact the branch-point to promote prespliceosome assembly. Mol. Cell 13, 367-376.
24. Smith, C.W. and Valcarcel, J. (2000). Alternative pre-mRNA splicing: the logic of combinatorial control. Trends Biochem. Sci. 25, 381-388.
25. Soule, H.D., Vazguez, J., Long, A., Albert, S., and Brennan, M. (1973). A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51, 1409-1416.
26. Soule, H.D., Maloney, T.M., Wolman, S.R., Peterson, W.D. Jr., Brenz, R., McGrath, C.M., Russo, J., Pauley, R.J., Jones, R.F., and Brooks, S.C. (1990). Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50, 6075-6086.
27. Stickeler, E., Kittrell, F., Medina, D., and Berget, S.M. (1999). Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18, 3574-3582.
28. Yuryev, A., Patturajan, M., Litingtung, Y., Joshi, R.V., Gentile, C., Gebara, M., and Corden, J.L. (1996). The C-terminal domain of the largest subunit of RNA polymerase II interacts with a novel set of serine/arginine-rich proteins. Proc. Natl. Acad. Sci. USA 93, 6975-6980.